President Donald Trump has unveiled a major healthcare initiative, announcing a historic agreement with Eli Lilly and Novo Nordisk to dramatically reduce prescription drug prices while reshoring U.S. medicine manufacturing. Through TrumpRx.com, Americans will gain access to medications at the lowest global prices under a “Most Favored Nation” deal. Trump hailed the move as a landmark victory for both healthcare affordability and U.S. jobs, emphasizing his commitment to lowering costs for weight-loss, diabetes, and other critical medications. The initiative is positioned as a direct challenge to pharmaceutical giants and aims to transform drug accessibility in the United States, making vital medications more affordable for millions of Americans. The announcement has sparked national attention, with widespread reactions from political leaders, healthcare experts, and industry insiders.
Be the first to comment